Stephane Fattori

6PUBLICATIONS
60CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 20, 2024
Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell Pyroptosis.

Anne-Charlotte Le Floch, Caroline Imbert, Nicolas Boucherit

|Jun 28, 2023
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer.

Stéphane Fattori, Aude Le Roy, Jemila Houacine

|Sep 27, 2022
Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer.

Philippe Rochigneux, Aaron Lisberg, Alejandro Garcia

|Aug 30, 2022
Therapeutic Targeting of Tumor-Infiltrating Regulatory T Cells in Breast Cancer.

Stephane Fattori, Hugo Roux, Emilie Connen

Pageof 1